STAT3 was activated by IL-6 in myeloma and prostate cancer cells [24,52,53], hepatocyte growth factor (HGF) and its receptor (c-MET) in leiomyosarcoma and breast cancer cells [54,55], and Src in breast cancer and melanoma cells [54,56]. Here, SRC is linked to breast carcinoma.